Cargando…

Costs and health-related quality of life in Alpha-1-Antitrypsin Deficient COPD patients

BACKGROUND: Alpha-1-Antitrypsin Deficiency (AATD) is an economically unexplored genetic disease. METHODS: Direct and indirect costs (based on self-reported information on healthcare utilization) and health-related quality of life (HRQL, as assessed by SGRQ, CAT, and EQ-5D-3 L) were compared between...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karl, Florian M., Holle, Rolf, Bals, Robert, Greulich, Timm, Jörres, Rudolf A., Karch, Annika, Koch, Armin, Karrasch, Stefan, Leidl, Reiner, Schulz, Holger, Vogelmeier, Claus, Wacker, Margarethe E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2017
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5392996/ https://www.ncbi.nlm.nih.gov/pubmed/28416015 http://dx.doi.org/10.1186/s12931-017-0543-8

Ejemplares similares

The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort
por: Wacker, Margarethe E, et al.
Publicado: (2017)

Assessing health-related quality of life in COPD: comparing generic and disease-specific instruments with focus on comorbidities
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Relative impact of COPD and comorbidities on generic health-related quality of life: a pooled analysis of the COSYCONET patient cohort and control subjects from the KORA and SHIP studies
por: Wacker, Margarethe E., et al.
Publicado: (2016)

Cardiovascular risk in patients with alpha-1-antitrypsin deficiency
por: Fähndrich, Sebastian, et al.
Publicado: (2017)

Determinants of healthcare utilization and costs in COPD patients: first longitudinal results from the German COPD cohort COSYCONET
por: Byng, Danalyn, et al.
Publicado: (2019)

The Distribution of Alpha-1 Antitrypsin Genotypes Between Patients with COPD/Emphysema, Asthma and Bronchiectasis
por: Veith, Martina, et al.
Publicado: (2020)

Comorbid Influences on Generic Health-Related Quality of Life in COPD: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Health-related quality of life associates with change in FEV(1) in COPD: results from the COSYCONET cohort
por: Lutter, Johanna I., et al.
Publicado: (2020)

Transfer factor for carbon monoxide in patients with COPD and diabetes: results from the German COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Relationship of hyperlipidemia to comorbidities and lung function in COPD: Results of the COSYCONET cohort
por: Kahnert, Kathrin, et al.
Publicado: (2017)

Case-finding for alpha1-antitrypsin deficiency in Kazakh patients with COPD
por: Zhumagaliyeva, Ardak, et al.
Publicado: (2017)

Results from a large targeted screening program for alpha-1-antitrypsin deficiency: 2003 - 2015
por: Greulich, Timm, et al.
Publicado: (2016)

Diagnosing Alpha-1-Antitrypsin Deficiency Using A PCR/Luminescence-Based Technology
por: Veith, Martina, et al.
Publicado: (2019)

Longitudinal stability of blood eosinophil count strata in the COPD COSYCONET cohort
por: Greulich, Timm, et al.
Publicado: (2018)

Excess Costs of Comorbidities in Chronic Obstructive Pulmonary Disease: A Systematic Review
por: Huber, Manuel B., et al.
Publicado: (2015)

Real world evaluation of a novel lateral flow assay (AlphaKit® QuickScreen) for the detection of alpha-1-antitrypsin deficiency
por: Greulich, Timm, et al.
Publicado: (2018)

Influence of body mass on predicted values of static hyperinflation in COPD
por: Alter, Peter, et al.
Publicado: (2018)

Health-related quality of life and chronic obstructive pulmonary disease in early stages – longitudinal results from the population-based KORA cohort in a working age population
por: Wacker, Margarethe E, et al.
Publicado: (2014)

Basic Determinants of Disease Knowledge in COPD Patients: Results from COSYCONET
por: Fischer, Carolina, et al.
Publicado: (2022)

The association of smoking status with healthcare utilisation, productivity loss and resulting costs: results from the population-based KORA F4 study
por: Wacker, Margarethe, et al.
Publicado: (2013)

Systematic Analysis of Self-Reported Comorbidities in Large Cohort Studies – A Novel Stepwise Approach by Evaluation of Medication
por: Lucke, Tanja, et al.
Publicado: (2016)

Treatment of COPD Groups GOLD A and B with Inhaled Corticosteroids in the COSYCONET Cohort – Determinants and Consequences
por: Lutter, Johanna I, et al.
Publicado: (2021)

Therapy with Plasma Purified Alpha1-Antitrypsin (Prolastin(®)) Induces Time-Dependent Changes in Plasma Levels of MMP-9 and MPO
por: Koepke, Janine, et al.
Publicado: (2015)

IgE is associated with exacerbations and lung function decline in COPD
por: Lommatzsch, Marek, et al.
Publicado: (2022)

Safety of biweekly α(1)-antitrypsin treatment in the RAPID programme
por: Greulich, Timm, et al.
Publicado: (2018)

Are health risk attitude and general risk attitude associated with healthcare utilization, costs and working ability? Results from the German KORA FF4 cohort study
por: Lutter, Johanna I., et al.
Publicado: (2019)

Impact of Education on COPD Severity and All-Cause Mortality in Lifetime Never-Smokers and Longtime Ex-Smokers: Results of the COSYCONET Cohort
por: Lutter, Johanna I, et al.
Publicado: (2020)

Heterogeneous pattern of differences in respiratory parameters between elderly with either good or poor FEV(1)
por: Karrasch, Stefan, et al.
Publicado: (2018)

Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry
por: Bernhard, Nikolas, et al.
Publicado: (2017)

The Multifaceted Effects of Alpha1-Antitrypsin on Neutrophil Functions
por: Janciauskiene, Sabina, et al.
Publicado: (2018)

Uric acid, lung function, physical capacity and exacerbation frequency in patients with COPD: a multi-dimensional approach
por: Kahnert, Kathrin, et al.
Publicado: (2018)

Effects of airway obstruction and hyperinflation on electrocardiographic axes in COPD
por: Alter, Peter, et al.
Publicado: (2019)

Prediction of air trapping or pulmonary hyperinflation by forced spirometry in COPD patients: results from COSYCONET
por: Alter, Peter, et al.
Publicado: (2020)

Prevalence of cardiac comorbidities, and their underdetection and contribution to exertional symptoms in COPD: results from the COSYCONET cohort
por: Alter, Peter, et al.
Publicado: (2019)

New Patient-Centric Approaches to the Management of Alpha-1 Antitrypsin Deficiency
por: Chorostowska-Wynimko, Joanna, et al.
Publicado: (2020)

Augmentation therapy for alpha-1 antitrypsin deficiency: towards a personalised approach
por: Stockley, Robert A, et al.
Publicado: (2013)

Alpha 1 Antitrypsin Therapy in Patients with Alpha 1 Antitrypsin Deficiency: Perspectives from a Registry Study and Practical Considerations for Self-Administration During the COVID-19 Pandemic
por: Herth, Felix J F, et al.
Publicado: (2021)

Impact of the COVID-19 pandemic on the behaviour and health status of patients with COPD: results from the German COPD cohort COSYCONET
por: Kahnert, Kathrin, et al.
Publicado: (2021)

Reference Values of Impulse Oscillometric Lung Function Indices in Adults of Advanced Age
por: Schulz, Holger, et al.
Publicado: (2013)

Impact of Lung Function and Exacerbations on Health-Related Quality of Life in COPD Patients Within One Year: Real-World Analysis Based on Claims Data
por: Stöber, Alisa, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_iv2rh1vqfn6dnl0r6oet08du2c